New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength

2Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Neostigmine is a clinical cholinesterase inhibitor, that is, commonly used to enhance the function of the cholinergic neuromuscular junction. Recent studies have shown that neostigmine regulates the immune-inflammatory response through the cholinergic anti-inflammatory pathway, affecting perioperative neurocognitive function. This article reviews the relevant research evidence over the past 20 years, intending to provide new perspectives and strategies for the clinical application of neostigmine.

Cite

CITATION STYLE

APA

Si, S., Zhao, X., Su, F., Lu, H., Zhang, D., Sun, L., … Xu, L. (2023). New advances in clinical application of neostigmine: no longer focusing solely on increasing skeletal muscle strength. Frontiers in Pharmacology. Frontiers Media SA. https://doi.org/10.3389/fphar.2023.1227496

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free